Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer
Clinical trial NCT00426556 · COMPLETED
Trial details
- NCT number
- NCT00426556
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2014-03-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.